BOCA RATON, Fla., April 26, 2018 /PRNewswire/ -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device companyspecializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that management will hold a conference call on Thursday, May 3, 2018 at 4:30
To access the conference call, the dial-in numbers are 855-940-9473 (U.S. Toll Free), 412-317-5220 (International), and 855-669-9657 (Canada Toll Free). Please direct the operator to be connected to the Sensus Healthcare call.
Following the conclusion of the conference call, a replay will be available through May 10, 2018 and can be accessed by dialing 877-344-7529 (U.S. Toll Free), 412-317-0088 (International), and 855-669-9658 (Canada Toll Free). All listeners should provide the following replay access code: 10119889. The call will also be archived on the Company's website for a period of time at www.sensushealthcare.com.
About Sensus HealthcareSensus Healthcare, Inc., is a medical device company that is committed to providing non-invasive and cost-effective treatment for non-melanoma skin cancers and keloids. Sensus uses a proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is a result of over a decade of dedicated research and development. Sensus has successfully incorporated SRT into its portfolio of treatment devices, the SRT-100™ and SRT-100 Vision™. To date, SRT technology has been used to effectively and safely treat oncological and non-oncological skin conditions in thousands of patients. Sensus recently launched Sensus Laser Systems, three next-generation devices that showcase the latest in technology and function for the aesthetic dermatology market. For more information, visit https://www.sensushealthcare.com.
Investor Contact:LHA Investor Relations Kim Sutton Golodetz(212) firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/sensus-healthcare-to-host-first-quarter-2018-financial-results-and-business-update-conference-call-on-may-3-2018-300636982.html
SOURCE Sensus Healthcare, Inc.
Subscribe to our Free Newsletters!
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...
Stereotypic movement disorder (SMD) is a motor disorder, associated with neurodevelopmental ...View All